Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a Locations section listing California, Georgia, and Nebraska as study sites.
    Difference
    0.4%
    Check dated 2025-12-23T21:55:25.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-25T11:41:16.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page no longer shows the government funding lapse notice that described NIH operations and potential processing delays.
    Difference
    0.3%
    Check dated 2025-11-18T07:16:32.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the study details page content and layout remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T21:14:01.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.
    Difference
    2%
    Check dated 2025-10-06T06:36:46.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Minor capitalization updates for disease names and a version bump from v3.0.2 to v3.1.0. No substantive changes to core content or availability.
    Difference
    0.2%
    Check dated 2025-09-29T03:14:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.